Hiroyuki Muroga
Comptroller/Controller/Auditor bij Institute of Immunology Co., Ltd.
Actieve functies van Hiroyuki Muroga
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Institute of Immunology Co., Ltd.
 Institute of Immunology Co., Ltd. Medical SpecialtiesHealth Technology Institute of Immunology Co., Ltd. engages in the manufacture and sale of diagnostic reagents and monoclonal antibodies for research purpose. It develops and produces Enzyme Immunoassay (EIA) kits related to infectious diseases such as hepatitis B as well as those for human hepatocellular growth factor determination. The firm also offers EIA kits for detecting hepatitis E virus antibody and for determining the genotypes of hepatitis B virus and offers immunization of 3 mice, evaluation, fusion, screening, cloning, ascites production and purification services to the research, clinical and medical industries. The company was founded by Tetsuo Nakamura on August 18, 1979 and is headquartered in Tokyo, Japan. | Comptroller/Controller/Auditor | - | - |
Loopbaan van Hiroyuki Muroga
Eerdere bekende functies van Hiroyuki Muroga
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| PERSEUS PROTEOMICS INC. | Comptroller/Controller/Auditor | - | - |
Statistieken
Internationaal
| Japan | 3 |
Operationeel
| Comptroller/Controller/Auditor | 2 |
Sectoraal
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PERSEUS PROTEOMICS INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Institute of Immunology Co., Ltd.
Institute of Immunology Co., Ltd. Medical SpecialtiesHealth Technology Institute of Immunology Co., Ltd. engages in the manufacture and sale of diagnostic reagents and monoclonal antibodies for research purpose. It develops and produces Enzyme Immunoassay (EIA) kits related to infectious diseases such as hepatitis B as well as those for human hepatocellular growth factor determination. The firm also offers EIA kits for detecting hepatitis E virus antibody and for determining the genotypes of hepatitis B virus and offers immunization of 3 mice, evaluation, fusion, screening, cloning, ascites production and purification services to the research, clinical and medical industries. The company was founded by Tetsuo Nakamura on August 18, 1979 and is headquartered in Tokyo, Japan. | Health Technology |
- Beurs
- Insiders
- Hiroyuki Muroga
- Ervaring
